Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
2.960
0.00 (0.00%)
At close: Oct 2, 2026, 4:00 PM EDT
3.180
+0.220 (7.43%)
After-hours: Oct 2, 2026, 7:50 PM EDT
Ernexa Therapeutics Market Cap
Ernexa Therapeutics has a market cap or net worth of $4.83 million as of October 2, 2026. Its market cap has decreased by -44.75% in one year.
Market Cap
4.83M
Enterprise Value
152.94K
1-Year Change
-44.75%
Ranking
Category
Stock Price
$2.96
ChartMarket Cap Chart
Since March 26, 2021, Ernexa Therapeutics's market cap has decreased from $197.27M to $4.83M, a decrease of -97.55%. That is a compound annual growth rate of -48.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 4.83M | -48.70% |
| Dec 31, 2025 | 9.42M | -37.64% |
| Dec 31, 2024 | 15.10M | 55.53% |
| Dec 29, 2023 | 9.71M | -41.18% |
| Dec 30, 2022 | 16.51M | -92.39% |
| Dec 31, 2021 | 217.02M | 10.01% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AIM ImmunoTech | 5.48M |
| Processa Pharmaceuticals | 5.40M |
| Kairos Pharma | 5.28M |
| Xenetic Biosciences | 5.25M |
| Liminatus Pharma | 5.24M |
| 60 Degrees Pharmaceuticals | 4.89M |
| Lexaria Bioscience | 4.76M |
| NuCana | 4.70M |